Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer

Author(s):
Henneman, L.; Miltenburg, M.H. van; Michalak, E.M.; Braumuller, T.M.; Jaspers, J.E.; Drenth, A.P.; Korte-Grimmerink, R. de; Gogola, E.; Szuhai, K. (0000-0002-1228-4245); Schlicker, A.; Ali, R. bin; Pritchard, C.; Huijbers, I.J.; Berns, A.; Rottenberg, S.; Jonkers, J.
Published
2015
Publication type
Article / Letter to editor
resistancemouse modelbreast cancerBRCA1PARP
Date issued
2015-07-07
Language
English
Is part of
Proceedings of the National Academy of Sciences (2015), Vol. 112, no. 27, p. 8409-8414
hdl
1887/102956
doi
10.1073/pnas.1500223112